![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.388, 2002-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Isoniazid programme to prevent TB cost effective in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Isoniazid programme to prevent TB cost effective in the US
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
US hep A vaccination programme successful
Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Home-based programme for CHF successful
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New framework for TB control in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. :